PNI – Morgans rates the stock as Add
The target price rises to $11.85 from $11.14 and the Add rating is unchanged.
Read MoreBroker News
AVN – Morgans rates the stock as Add
The Add rating is maintained and the target is increased to $3.26 from $3.12.
Read MorePNI – Macquarie rates the stock as Outperform
Outperform maintained. Target rises to $12.28 from $12.26.
Read MoreCGC – Credit Suisse rates the stock as Outperform
Outperform rating and $4.15 target are unchanged.
Read MoreAIA – UBS rates the stock as Sell
Sell maintained. Price target is NZ$6.65.
Read MoreANZ – Morgans rates the stock as Add
The Add rating and $34.50 target are maintained.
Read MoreNHC – Morgans rates the stock as Add
The target price also increases to $2.08 from $1.70 and the Add rating is unchanged.
Read MoreLLC – Macquarie rates the stock as Neutral
Target is reduced to $11.47 from $12.99.
Read MoreA2M – Credit Suisse rates the stock as Underperform
UBS upgrades EPS forecasts for FY22 and FY23 by 2% and 4%, and raises the target price to $5.50 from $5. The Underperform rating is unchanged.
Read MoreAMA – UBS rates the stock as Downgrade to Neutral
The rating is downgraded to Neutral from Buy and the target price falls to $0.56 from $0.70.
Read MoreHLS – Macquarie rates the stock as Outperform
Outperform retained. Target rises to $4.85 from $4.70.
Read MoreLLC – Credit Suisse rates the stock as Outperform
Credit Suisse lowers the target price to $12.94 from $13.47 but continues to see long-term value for patient investors.
Read MoreTLS – UBS rates the stock as Downgrade to Neutral
The broker has lowered the rating on Telstra Corp to Neutral and the price target increases to $3.90 from $3.70.
Read MoreIEL – Morgans rates the stock as Add
The Add rating is retained and the price target is increased to $29.10 from $28.48.
Read MoreNAN – Morgans rates the stock as Add
The broker lowers forecasts, mainly in FY21, to reflect an exchange rate adjustment to consumables. The target price have been revised down to $6.57 from $6.69.
Read MoreAST – UBS rates the stock as Neutral
The Neutral rating and $1.80 target are retained.
Read MoreMGR – Credit Suisse rates the stock as Outperform
The target price is increased to $3.06 from $2.63, a function of earnings changes as well as the removal of discounts for the office and retail portfolios.
Read MoreOTW – Morgans rates the stock as Hold
The Hold rating is unchanged and the target price increases to $4.66 from $4.25 after adjustments for lower earnings, offest by a change in valuation methodology.
Read MoreAPT – Macquarie rates the stock as Outperform
While maintaining an Outperform rating Macquarie acknowledges the stock is no longer looking “cheap” versus peers in the segment, but is not overpriced either. Target is raised to $140 from $120.
Read MoreTLS – Morgans rates the stock as Upgrade to Add
The rating is upgraded to Add from Hold and the target price rises to $4.19 from $3.33.
Read MoreQUB – Citi rates the stock as Buy
Overall, the broker sees potential upside risk over the medium term and lifts the target price to $3.61 from $3.57. The Buy rating is maintained.
Read MoreMGR – UBS rates the stock as Buy
UBS retains a Buy rating and raises the target to $3.15 from $2.84.
Read MoreING – Macquarie rates the stock as Downgrade to Neutral
The broker believes the growth cycle in markets has peaked and downgrades to Neutral from Outperform. Target is raised to $4.03 from $3.98.
Read MoreAPT – UBS rates the stock as Sell
The re-evaluation of the sales outlook drives an increase in the target to $42 from $37. UBS maintains a Sell rating on valuation grounds.
Read MoreBHP – Macquarie rates the stock as Outperform
Macquarie observes earnings upgrade momentum remains strong and retains an Outperform rating and $63 target.
Read MoreISD – Morgans rates the stock as Hold
The target price remains at $0.175, which is the level of the current cash takeover offer from Access Intelligence. The Hold rating is unchanged.
Read MoreSXL – UBS rates the stock as Buy
As the TEN overhang has now removed and advertising markets are continuing to improve the broker retains a Buy rating. Target is $2.50.
Read MoreASB – Credit Suisse rates the stock as Outperform
Outperform rating and $2.75 target maintained.
Read MoreCHC – Credit Suisse rates the stock as Neutral
Guidance is for earnings per security of at least $0.57 and the broker would not be surprised if the actual outcome is higher. Neutral rating maintained. Target rises to $15.43 from $14.40.
Read MoreMPL – Macquarie rates the stock as Neutral
Macquarie maintains a preference for Medibank Private over nib Holdings ((NHF)). The Neutral rating and $2.80 target are maintained.
Read MoreFPH – UBS rates the stock as Sell
The Sell rating and target price of $22.65 are retained.
Read MoreWBC – Citi rates the stock as Buy
Buy rating and target price of $29.50 are both retained.
Read MoreS32 – Credit Suisse rates the stock as Upgrade to Outperform
Credit Suisse lifts the rating for South32 to Outperform from Neutral and raises the target price to $3.60 from $3.
Read MoreBLD – Macquarie rates the stock as Outperform
After a short period of restriction Macquarie now rates Boral as Outperform with a target of $7.80.
Read MoreCGC – Credit Suisse rates the stock as Outperform
The Outperform rating and $4.15 target are unchanged.
Read MoreAVN – Macquarie rates the stock as Outperform
Macquarie suspects there is additional upside to come. Outperform. Target is raised to $3.23 from $3.15.
Read MorePME – Morgans rates the stock as Downgrade to Reduce
While the broker increases the target price to $49.69 from $41.30, current prices are considered unsustainable in the short term.
Read MoreLFG – Citi rates the stock as Buy
The Buy rating and $8.50 target are retained.
Read MoreCSL – Citi rates the stock as Downgrade to Neutral
Citi downgrades to Neutral from Buy given the stock has outperformed since March. Target is steady at $310.
Read MoreABP – Credit Suisse rates the stock as Downgrade to Neutral
The broker downgrades to Neutral from Outperform, noting uncertainty exists over how quickly capital is redeployed. Target is raised to $3.21 from $3.04.
Read More
